LASERSCOPE
8-K, 2000-02-10
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: BEI MEDICAL SYSTEMS CO INC /DE/, SC 13G, 2000-02-10
Next: FINET COM INC, 3, 2000-02-10



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934



       Date of Report (Date of earliest event reported): FEBRUARY 10, 2000

                                   LASERSCOPE
             (Exact name of Registrant as specified in its charter)

<TABLE>
<S>                                               <C>                                          <C>
        CALIFORNIA                                     000-18053                                   77-0049527
(State or other jurisdiction of                   (Commission File Number)                     (I.R.S. Employer
incorporation or organization)                                                                 Identification No.)
</TABLE>

                               3052 ORCHARD DRIVE
                               SAN JOSE, CA 95134
               (Address of principal executive offices) (Zip code)


                                 (408) 943-0636
              (Registrant's telephone number, including area code)

                                 NOT APPLICABLE
          (Former name or former address, if changed since last report)


<PAGE>   2

ITEM 5. OTHER EVENTS

     (a)  On January 18, 2000 Laserscope (the "Company") issued a press release
announcing that it had completed a private placement of common stock providing
net proceeds to the Company of approximately $1.8 million. The placement of
common stock to accredited investors was managed by Taglich Brothers Inc.



ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

     (a)  Not applicable.

     (b)  Not applicable.

     (c)  Exhibits.

          20.1      Press Release dated January 18, 2000 announcing the private
                    placement. [See Exhibit Index.]

<PAGE>   3

                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.


                                       LASERSCOPE
                                       (Registrant)



Date:  February 10, 2000                By: /s/ Dennis LaLumandiere
                                        -------------------------------------
                                           Dennis LaLumandiere
                                           Vice President, Finance,
                                           Chief Financial Officer and
                                           Assistant Secretary


<PAGE>   4

                                INDEX TO EXHIBITS

<TABLE>
<CAPTION>
                                                                               SEQUENTIALLY
EXHIBIT                                                                          NUMBERED
NUMBER            DESCRIPTION                                                      PAGE
- -------           -----------                                                  ------------
<S>               <C>                                                               <C>

20.1              PRESS RELEASE DATED JANUARY 18, 2000 ANNOUNCING                   5
                  THE PRIVATE PLACEMENT.
</TABLE>


<PAGE>   1
                                                                    Exhibit 20.1

LASERSCOPE COMPLETES PRIVATE FINANCING

     SAN JOSE, Calif.-- Jan. 18, 2000--Laserscope (Nasdaq:LSCP - news) today
announced that it completed a private placement of common stock providing net
proceeds to the Company of approximately $1.8 million. The placement to
accredited investors was managed by Taglich Brothers, D'Amadeo, Wagner &
Company, Incorporated.

     Laserscope designs, manufactures, sells and services on a worldwide basis
an advanced line of medical laser systems and related energy delivery devices
for the office, outpatient surgical center, and hospital markets. More
information about Laserscope can be found on the Company's Web Site at
www.laserscope.com.

     Except for historical information presented, the matters discussed in this
announcement may contain forward-looking statements that involve risks and
uncertainties. These risks are detailed from time to time in the Company's
public disclosure filings with the U.S. Securities and Exchange Commission
(SEC). Copies of Laserscope's most recent forms 10K and 10Q are available upon
request from its Investor Relations Department.

Contact:

     Laserscope
     Richard Wood, IR/Media or
     Dennis LaLumandiere, Financial, 408/943-0636


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission